Valeant – Valeant Pharmaceuticals Announces FDA Approval Of Jublia® for the Treatment of Onychomycosis.

Smith & Nephew in Play as Device Makers Combine: Real M&A – Bloomberg.

In a floor vote yesterday, the Assembly unanimously agreed to make podiatric services a Medi-Cal benefit. Podiatry had been an optional Medi-Cal benefit until 2009 when it was cut because of budget constraints along with a number of other services, including optometry and adult dental services. Some of those services, including podiatry, were reinstated at…

Medicine’s Top Earners Are Not the M.D.s – NYTimes.com.